INS and type 2 diabetes mellitus: To assess possible risks of Lac-Phe administration considering its association with insulin resistance and type 2 diabetes, the effect of Lac-Phe on insulin signaling was examined in the insulin-responsive cell lines HepG2 (as a surrogate for liver cells) and differentiated C2C12 (as a surrogate for skeletal muscle cells).